Organon and Henlius announce FDA approval of POHERDY, the first and only pertuzumab biosimilar in the US, which is ...

Released in 2023, PREVENT is a tool estimating CVD, ASCVD, and heart failure risk over 10 or 30 years for adults as young as ...

The Dallas Cowboys didn't spend aggressively in free agency to add a running back like some fans wanted, but owner/general ...

A new Northwestern Medicine study introduces a first-of-its-kind online calculator that uses percentiles to help younger ...